# Kardigan, Inc.: financial statements, quarterly

KARD · Nasdaq · CIK 2123613 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/kard.md) · [Financials](/companies/kard/financials.md) · [Filings](/companies/kard/filings.md) · [Insiders](/companies/kard/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/kard/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | period not labelled (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Research and development | $m | not reported | [35.8](/filings/0001193125-26-343418.md) | not reported | [56.4](/filings/0001193125-26-343418.md) |
| Operating income | $m | not reported | [(57.1)](/filings/0001193125-26-343418.md) | not reported | [(119)](/filings/0001193125-26-343418.md) |
| Income tax | $m | not reported | [0.0](/filings/0001193125-26-343418.md) | not reported | [0.0](/filings/0001193125-26-343418.md) |
| Net income | $m | [(18.0)](/filings/0001193125-26-343418.md) | [(57.4)](/filings/0001193125-26-343418.md) | [(56.1)](/filings/0001193125-26-343418.md) | [(116)](/filings/0001193125-26-343418.md) |
| Diluted EPS | $ per share | not reported | [(4.64)](/filings/0001193125-26-343418.md) | not reported | [(4.61)](/filings/0001193125-26-343418.md) |
| Basic EPS | $ per share | not reported | [(4.64)](/filings/0001193125-26-343418.md) | not reported | [(4.61)](/filings/0001193125-26-343418.md) |

- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | period not labelled (2025-12-31) | period not labelled (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | [90.1](/filings/0001193125-26-343418.md) | [109](/filings/0001193125-26-343418.md) | not reported | [384](/filings/0001193125-26-343418.md) |
| Current assets | $m | not reported | not reported | not reported | [345](/filings/0001193125-26-343418.md) | not reported | [610](/filings/0001193125-26-343418.md) |
| Total assets | $m | not reported | not reported | not reported | [391](/filings/0001193125-26-343418.md) | not reported | [722](/filings/0001193125-26-343418.md) |
| Current liabilities | $m | not reported | not reported | not reported | [37.5](/filings/0001193125-26-343418.md) | not reported | [70.0](/filings/0001193125-26-343418.md) |
| Total liabilities | $m | not reported | not reported | not reported | [55.1](/filings/0001193125-26-343418.md) | not reported | [106](/filings/0001193125-26-343418.md) |
| Shareholders' equity | $m | [(83.2)](/filings/0001193125-26-343418.md) | [(98.3)](/filings/0001193125-26-343418.md) | [(151)](/filings/0001193125-26-343418.md) | [(250)](/filings/0001193125-26-343418.md) | [(301)](/filings/0001193125-26-343418.md) | [616](/filings/0001193125-26-343418.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Shares

| Line item | Unit | period not labelled (2025-06-30) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [12.4](/filings/0001193125-26-343418.md) | [25.2](/filings/0001193125-26-343418.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 93,503,699 at 2026-08-07, from the cover of the [10-Q filed 2026-08-11](/filings/0001193125-26-343418.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.